KPP
MDT icon

Kings Path Partners’s Medtronic MDT Stock Holding History

Kings Path Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,677
Closed -$1.01M – 278
2024
Q4 		$1.01M Hold
12,677
– – 0.43% 59
2024
Q3 		$1.14M Hold
12,677
– – 0.48% 51
2024
Q2 		$998K Buy
+12,677
New +$1.04M 0.47% 55

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kings Path Partners's MDT Position: Q1 2025 in Review

Kings Path Partners sold out of Medtronic (MDT) in Q1 2025, closing a stake of 12,677 shares — an estimated $1.01M sold.

Kings Path Partners first reported a position in MDT in Q2 2024 and held it in 3 quarters. The position peaked at $1.14M in Q3 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Kings Path Partners reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Kings Path Partners sold 12,677 Medtronic shares in Q1 2025, an estimated $1.01M.
  • Kings Path Partners first reported a position in Medtronic in Q2 2024 and held it in 3 quarters.
  • Kings Path Partners's Medtronic position peaked at $1.14M in Q3 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Kings Path Partners's 13F filing for Q1 2025, filed 4 Apr 2025.